How a grant writing service aims to break new ground in medtech

This approach has already seen Cresco help several projects receive valuable investment, some of which have ultimately proved to be lifesaving.

Cresco continues to provide its usual services including IP advice and commercialisation, technology scouting and project management, but it also offers a bespoke service that is specifically tailored to healthcare projects.

By drawing on the team’s experience in healthcare and by understanding exactly what different funders require, Cresco has recently won more than £6.5 million in funding for several different projects.

Cresco’s team integrates itself fully within its healthcare clients; enabling it to identify gaps within that team’s existing knowledge and expertise that is required to successfully achieve the clinical adoption of the technology.

Building on that, Cresco seeks to identify opportunities and apply for funding in order to progress the technology along the clinical development pathway.

In recent months, Cresco has won more than £6.5 million in Innovate UK biomedical funding. This includes a £1.5 million project to develop a medical device for treatment of cancer; a £3.9 million drug development project; and a £1.6 million project that will enable an intraperitoneal chemotherapy delivery system to be developed.

Cresco CEO Jo Derbyshire said: “We have been fortunate in being able to attract a really excellent team of writers with a world-class background in health innovation and commercialisation.

“The sector is quite a cohesive community, and we get companies approach us based upon recommendations. As such, we have had some significant successes already this year.

“That we’re celebrating these wins so far this year demonstrates that, by launching our new dedicated team, our approach to healthcare funding is certainly a step in the right direction, not only for us but for our existing and potential clients in healthcare.” Med-Tech Innovation